Silica–lipid hybrid (SLH) formulations enhance the oral bioavailability and efficacy of celecoxib: An in vivo evaluation
Tri‐Hung Nguyen(Monash University), Ben J. Boyd(Australian Regenerative Medicine Institute), Angel Tan(University of South Australia), Christopher J. H. Porter(Monash University), Leilani L. Santos(Royal Women's Hospital), Devi Ngo(Monash Medical Centre), Glenn A. Edwards(The University of Melbourne), Clive A. Prestidge(University of South Australia)
Cited by 51
Related Papers
From sewer to saviour — targeting the lymphatic system to promote drug exposure and activity
|Nature Reviews Drug Discovery|2015|634
Peptide-based biosensors
|Talanta|2015|274
Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolonged pain relief
|Science Translational Medicine|2017|240
Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis
|Arthritis & Rheumatism|1998|160
Lipids and polymers in pharmaceutical technology: Lifelong companions
|International Journal of Pharmaceutics|2019|146